Kamal Bakri

Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-Line Therapy in Advanced-Stage IIIB/IV Non–Small-Cell Lung Cancer

Mark A. Socinski, Michael J. Schell, Amy H. Peterman et al. · Journal of Clinical Oncology · 2002 · 120 citations

Advanced Nsclc, Optimal Duration, Medicine +15

Second‐line, low‐dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first‐line chemotherapy with carboplatin plus paclitaxel

Mark A. Socinski, Michael J. Schell, Kamal Bakri et al. · Cancer · 2002 · 55 citations · Full text

Racial Differences in Clinical Outcomes From Metastatic Breast Cancer: A Pooled Analysis of CALGB 9342 and 9840—Cancer and Leukemia Group B

Blasé N. Polite, Constance Cirrincione, Gini F. Fleming et al. · Journal of Clinical Oncology · 2008 · 37 citations · Full text

A Randomized Phase II Trial of First-Line Treatment with Gemcitabine, Erlotinib, or Gemcitabine and Erlotinib in Elderly Patients (Age ≥70 Years) with Stage IIIB/IV Non-small Cell Lung Cancer

Thomas E. Stinchcombe, Amy H. Peterman, Carrie B. Lee et al. · Journal of Thoracic Oncology · 2011 · 36 citations · Full text

Oncology, Elderly Patients, Medicine +7

Adenosquamous carcinoma of the thyroid after radiotherapy for Hodgkin's disease a case report and review

Kamal Bakri, Katsutaro Shimaoka, Uma Rao et al. · Cancer · 1983 · 28 citations · Full text

Health Sciences, Radiation Therapy, Medicine +11